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Apoptosis and JNK activation are differentially regulated by Tubular atrophy has repeatedly been shown to be one
Fas expression level in renal tubular epithelial cells. of the best histologic predictors of renal disease progres-
Background. In chronic renal disease, renal tubular epithe- sion in biopsy series that include specimens from hetero-
lial cell (RTC) Fas expression is up-regulated, leading to apo- geneous glomerular diseases [1–3], and renal tubular epi-ptotic RTC deletion and tubular atrophy. In vitro, cytokine- or
thelial cell (RTC) apoptosis has been proposed as onehypoxia-induced up-regulation of Fas expression is associated
pathogenetic mechanism of tubular atrophy [4–7]. Multi-with RTC apoptosis. In contrast, constitutively expressed, low
level RTC Fas does not mediate apoptosis, suggesting that Fas ple studies have demonstrated that RTC constitutively
may be coupled to expression level-dependent RTC signaling express low level Fas (CD95, APO-1) in normal kidney
pathways. Fas is known to signal through JNK in many systems, in vivo [6, 8], while RTC Fas expression is increased in
but the requirement of JNK activation for apoptosis remains animal models of acute and chronic renal disease [6, 9, 10].controversial.
RTC also constitutively express cell surface Fas in vitroMethods. To determine if RTC Fas regulates JNK activity
[6, 7, 9, 11], which can be up-regulated with stimuli suchand apoptosis, human RTC were transfected with graded con-
as cytokines or hypoxia that model aspects of glomerularcentrations of a eukaryotic expression vector for murine Fas.
Apoptosis was measured by annexin V, TUNEL and PARP injury [6, 7, 9]. It is clear that in cells with abundant Fas
cleavage assays. JNK activity was determined by immune com- expression, like Jurkat T cells or RTC with Fas expression
plex kinase assay and/or immunoblots with phospho-specific induced by interleukin-1 (IL-1) or hypoxia, Fas activates
JNK antibodies, in the presence or absence of co-expressed
pro-apoptotic signaling pathways [6, 7, 9, 12].dominant negative JNK constructs.
In contrast to the established role of RTC Fas follow-Results. Fas antibody stimulation of RTC with high Fas ex-
ing induced expression, RTC with constitutively low levelspression levels (to model RTC phenotype in renal disease)
caused a tenfold increase in apoptosis, while RTC with low of Fas fail to undergo apoptosis after agonistic Fas anti-
level Fas expression (to model normal RTC phenotype) were body exposure [7, 11]. These data suggest that despite
apoptosis-resistant. Fas ligation activated JNK in RTC express- detectable Fas expression, anti-apoptotic molecules, which
ing low levels of Fas, but not in apoptosis-sensitive RTC with
prevent Fas activation (soluble Fas or soluble Fas ligand)increased Fas expression. Dominant negative JNK co-expres-
[13, 14] or inhibit pro-apoptotic signaling pathways (bcl-2,sion failed to inhibit apoptosis in RTC expressing high levels
IAPs or FLIPs) [15], may prevent apoptosis when Fas,of Fas, suggesting that JNK is neither necessary, nor sufficient,
for Fas-dependent apoptosis. constitutively expressed at low density on the cell sur-
Conclusions. At high levels of expression, RTC Fas promotes face, interacts with its ligand. Predominance of such anti-
apoptosis in a JNK-independent manner. At low basal expres- apoptotic mechanisms in normal kidney is consistent
sion, Fas induces JNK activation, but not apoptosis, consistent
with both low basal RTC turnover, and the paradigm thatwith novel roles for RTC Fas as a mediator of cell stress or
apoptosis is a default pathway that is averted by constantchronic inflammation.
generation of survival signals [16]. Although these mech-
anisms provide an explanation for prevention of apoptosis
in the presence of Fas expression, low levels of expressedKey words: cell death, CD95, inflammatory mediators, signal transduc-
tion, protein kinases, progressive renal disease. Fas may also mediate functions that are apoptosis-inde-
pendent. For example, Fas and the tumor necrosis factorReceived for publication July 10, 2000
(TNF) receptor share structural homology [17], and bothAnd in revised form January 16, 2001
Accepted for publication January 31, 2001 have been linked to apoptosis-independent functions
such as inflammation and fibrosis [18–21]. Furthermore, 2001 by the International Society of Nephrology
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Fas stimulates signaling molecules that are activated by Transient transfections
inflammatory cytokines, such as c-Jun NH2-terminal ki- Transient, rather than stable, transfections were em-
nase (JNK) and nuclear factor-B (NF-B) [22, 23]. ployed to avoid activation of signaling pathways in stable
While NF-B convincingly has been shown to regulate transfectants, which may reflect adaptive mechanisms,
anti-apoptotic programs [22], the role of JNK in apopto- rather than direct activation of Fas. HRPT (0.25  106)
sis is more controversial. Although multiple studies indi- were plated in six-well dishes, and cultured overnight
cate that the JNK activation mediates apoptosis, an anti- in DMEM–F-12  10% fetal bovine serum, to achieve
apoptotic role for JNK has also been described in some approximately 80% confluence. Cells were then washed
circumstances [22, 24–26]. in serum-free DMEM, and maintained in DMEM for
In contrast to conditions characterized by up-regulated two hours. HRPT were transiently transfected with the
RTC Fas expression, with RTC Fas functioning as a proto- following constructs: murine Fas cDNA (gift from Dr. S.
typical death receptor, which may facilitate tubular atro- Nagata) [28] subcloned into pcDNA3 expression plasmid
phy, we have hypothesized that constitutively-expressed (Invitrogen, Carlsbad, CA, USA); green fluorescence
low abundance RTC Fas functions like a cytokine recep- protein (GFP) cDNA (Clontech, Palo Alto, CA) sub-
tor and may promote renal inflammation. To address cloned into pcDNA3; nonphosphorylatable, dominant
this hypothesis, a model system was developed whereby negative, HA-tagged JNK cDNAs (JNK1-and JNK2-
murine Fas was expressed at various levels in human APF) subcloned into LNCX retroviral plasmid vector
RTC, which permitted determination of the effects of (gift from Dr. L. Heasley) [29]. HRPT cells were incu-
different Fas expression levels on apoptosis and JNK bated with plasmid (2 g/well) plus cationic liposome
activation. Our results demonstrate that at high levels (10 L/well; Superfect, Qiagen, Valencia, CA, USA)
of expression, Fas promotes apoptosis in a JNK-indepen- complexes in serum-free DMEM for three hours at 37C.
dent manner. At low expression levels, Fas induces JNK To enhance cDNA construct expression, transfected
activation, but not apoptosis, which is consistent with a cells were maintained for an additional 24 hours in com-
novel role for RTC Fas as a mediator of chronic inflam- plete media containing DMEM-F12  10% fetal bovine
mation. serum. Transfection efficiency was determined in each
experiment by calculating the percentage of cells ex-
pressing GFP. Values routinely ranged from 20% toMETHODS
30%, and were identical between conditions within an
Antibodies individual experiment.
Antibodies used in this study included: rabbit anti-
Immunofluorescence microscopymouse Fas IgG, rabbit antihuman JNK IgG (Santa Cruz
Biotechnology, Santa Cruz, CA, USA); peroxidase-con- Methods previously described in detail for tissue sec-
jugated goat antirabbit IgG, peroxidase-conjugated goat tions and cell suspensions have been modified for cell
antimouse IgG (Amersham Pharmacia Biotech, Arling- culture monolayers [6, 7]. HRPT cells maintained on
ton Heights, IL, USA); agonistic hamster antimouse Fas sterile, glass coverslips within six-well plates were fixed in
IgG, mouse antihuman poly(ADP-ribose) polymerase paraformaldehyde (4%, 10 minutes, room temperature).
(PARP) IgG (Pharmingen, San Diego, CA, USA); bio- Fixed cells were washed with phosphate-buffered saline
tinylated goat antihamster IgG, Texas red-conjugated (PBS) and incubated with primary antibodies, followed
streptavidin, phycoerythrin (PE)-conjugated streptavi- by biotinylated secondary antibodies and Texas red-con-
din (Vector Laboratories, Burlingame, CA, USA); anti- jugated avidin. Negative controls were cells incubated
phosphospecific JNK IgG (New England Biolabs, Bev- with PBS alone or with isotype-identical IgG, which was
erly, MA, USA); mouse anti-HA IgG (Roche Molecular immunoreactive with an irrelevant epitope. Coverslips
Biochemicals, Indianapolis, IN, USA); agonistic mouse were mounted in antifade, aqueous media (Vectashield,
antihuman Fas IgM (Kamiya Biomedical, Seattle, WA, Vector Laboratories) containing 4,6 diamidino-2-phe-
USA). nylindole (DAPI) on standard microscope slides. Ran-
dom fields were viewed at 40 magnification using an
Cell culture Olympus epifluorescence microscope (Tokyo, Japan)
Human renal proximal tubular (HRPT) cells (gift from with appropriate fluorescence filters. Representative
Dr. L. Racusen) were derived from human proximal fields were photographed with a Spot Digital System
tubule and have been extensively characterized [6, 7, camera and Image Pro software system (Diagnostic In-
27]. HRPT cells were maintained in Dulbecco’s modified struments, Sterling Heights, MI, USA).
Eagle’s medium (DMEM)-F12 (Gibco BRL, Rockville,
Immunoblot analysisMD, USA)  10% fetal bovine serum (Hyclone, Logan,
UT, USA)  1% penicillin/streptomycin (Sigma, St. Methods have previously been described in detail [30].
Briefly, HRPT cell monolayers were lysed and denaturedLouis, MO, USA).
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in boiling sodium dodecyl saline-polyacrylamide gel elec- combined with 20 mol/L adenosine 5-triphosphate
(ATP), and 5 Ci [-32P] ATP. The kinase reaction wastrophoresis (SDS-PAGE) buffer (125 mmol/L Tris, pH 6.8,
2% SDS, 5% glycerol, 1% -mercaptoethanol, 0.003% terminated with 40 L Laemmli sample buffer (125
mmol/L Tris-HCl, pH 6.8, 20% glycerol, 4% SDS, 2%bromphenol blue) for five minutes. Samples (20 g/lane)
were resolved by 12% SDS-PAGE and transferred to -mercaptoethanol). After boiling for five minutes, sam-
ples were resolved by 10% SDS-PAGE. Gels werepolyvinylidine difluoride (PVDF) membranes. Blots
were blocked in 5% dried milk and 2% bovine serum stained with Coomassie blue, de-stained with 20% meth-
anol, 10% acetic acid and 70% H2O, and dried. Incorpo-albumin, probed with primary antibody (1 g/mL, 1 hour,
room temperature), and then peroxidase-conjugated rated [32P] was visualized by autoradiography.
IgG (1:5000, 1 hour, room temperature). Band intensity
Apoptosis detection by annexin V andwas detected by enhanced chemiluminescence according
chromatin labelingto the manufacturer’s instructions (Amersham Phar-
macia Biotech, Arlington Heights, IL, USA) and expo- Apoptotic cells were identified by labeling external-
ized phosphatidylserine with annexin V according to thesure to Kodak Biomax ML film (Eastman Kodak, Roch-
ester, NY, USA). manufacturer’s directions (Roche Molecular Biochemi-
cals) as previously described [7]. Briefly, HRPT cells
Fas expression by dual color flow cytometry cultured on coverslips were washed in PBS and then
incubated with biotin-conjugated annexin V in a bufferHuman renal proximal tubular cells were transfected
with GFP and mouse Fas cDNAs as described above, containing 140 mmol/L NaCl, 10 mmol/L HEPES/
NaOH, pH 7.4, 5 mmol/L CaCl2 for 15 minutes at roomfixed in paraformaldehyde (1%, 1 hour, 4C) and lifted by
incubation with ethylenediaminetetraacetic acid (EDTA; temperature. Coverslips were washed in the HEPES
buffer, incubated with Texas red-conjugated avidin (1:300,5 mmol/L, 10 minutes, 37C). Fas expression was deter-
mined by sequential incubation with hamster antimouse 20 minutes, 4C), and fixed in paraformaldehyde (4%,
10 minutes, room temperature). Monolayers were viewedFas IgG (2 106 cells/g antibody, 1 hour, room temper-
ature), biotinylated goat antihamster IgG and PE-conju- by fluorescence microscopy as described above, and apo-
ptotic cells were defined by fluorescent labeling of atgated streptavidin. All cells were resuspended in PBS
and assayed for GFP and Fas expression by flow cytome- least half of the plasma membrane perimeter. Nuclear
morphology was simultaneously determined by chroma-try (FACScan; Becton Dickinson, San Jose, CA, USA)
as previously described [6, 7], using appropriate filters tin labeling with DAPI. Morphology consistent with an
apoptotic phenotype included apoptotic bodies or pyk-for GFP and PE fluorescence. Analyses were performed
with a Macintosh Power PC computer (7600/132; Apple nosis, according to established criteria [32, 33]. The per-
centage of apoptotic cells was calculated from a total ofComputer, Cupertino, CA, USA) and appropriate soft-
ware (Becton Dickinson). 200 to 300 transfected cells per experimental condition,
which were identified by GFP fluorescence from ran-
JNK activity by immune complex kinase assay domly selected fields. All observations were made in a
blinded fashion with respect to experimental group byMethods have previously been described in detail [31].
Briefly, HRPT cells were lysed in RIPA buffer [150 at least two observers.
mmol/L NaCl, 50 mmol/L Tris, pH 7.2, 5 mmol/L EDTA,
Apoptosis detection by TUNEL1 mmol/L Na3VO4, 1% (wt/wt) Triton X-100, 0.1 mmol/L
phenylmethylsulfonyl fluoride (PMSF), 10 g/mL leu- Apoptotic nuclei were detected by the terminal deoxy-
ribonucleotide transferase (TdT)-catalyzed DNA end la-peptin, and 20 g/mL aprotinin]. Cell lysates, containing
equal amount of protein (400 g), were sequentially beling (TUNEL) technique according to the manufactur-
er’s instructions (Oncor, Gaithersburg, MD, USA) asprecleared with purified non-immune rabbit IgG and
goat anti-rabbit IgG-agarose beads at 4C for 60 minutes. previously described [6]. Briefly, 1% paraformaldehyde-
fixed HRPT cultured on coverslips were incubated withAfter centrifugation at 10,000  g, supernatants were
incubated overnight at 4C on a rotating platform with TdT and digoxigen-labeled dUTP, followed by FITC-
conjugated antidigoxigen IgG. Negative controls were1 g rabbit polyclonal anti-JNK IgG and 25 L goat
anti-rabbit IgG-agarose. After centrifugation, immuno- cells incubated without TdT. Monolayers were viewed
at 40 magnification using an Olympus epifluorescenceprecipitates were washed twice with lysis buffer and once
with kinase buffer (20 mmol/L HEPES, pH 7.6, 20 microscope with a fluorescein filter. The percentage of
fluorescent, apoptotic nuclei was calculated from a totalmmol/L MgCl2, 25 mmol/L -glycerol phosphate, 0.1
mmol/L Na3VO4, 2 mmol/L dithiothreitol). Immunopre- of 200 to 300 cells per condition, which were identified
by DAPI staining of all nuclei, from four to six randomlycipitate-associated kinase activity was assayed at 30C
for 20 minutes in 30 L kinase buffer containing recom- selected fields. All observations were made in a blinded
fashion with respect to experimental group.binant ATF-2 or GST-c-Jun (0.5 mg) as the substrate,
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Fig. 1. Human renal tubular epithelial cells (RTC) express transfected
Fig. 2. Mouse Fas cDNA-transfected human RTC are susceptible tomurine Fas on the cell surface. (A) Human renal proximal tubule
apoptosis. (A) HRPT cells were co-transfected with GFP cDNA (1 g/(HRPT) cells were transfected with mock vector (pcDNA3) or murine
well), to mark transfected cells, and murine Fas cDNA expression vectorFas cDNA (1 g/well). Lysates (20 g protein/lane) were resolved by
(1 g/well). Fas cDNA-transfected RTC were then incubated with ago-SDS-PAGE and probed for Fas expression by immunoblot analysis
nistic antimouse Fas antibodies (5 g/ml, 14 hours, 37C) and assayedwith rabbit antimouse Fas IgG, as described in the Methods section.
for apoptosis by annexin V labeling of externalized phosphatidylserine(B–D) Fas localization was determined in HRPT cells co-transfected
and DAPI staining of chromatin, as described in the Methods. Thewith green fluorescence protein (GFP) and Fas cDNA reporter con-
transfected RTCs, indicated by GFP fluorescence (green), demon-structs by fluorescence microscopy. (B) Transfected cells were identified
strated an apoptotic morphology that included external plasma mem-by GFP fluorescence. (C) Fas expression was determined following
brane labeling with annexin V (red) and chromatin fragmentation andsequential incubation with hamster antimouse Fas IgG, biotinylated
condensation (arrows). The single untransfected cell in this field dis-goat antihamster IgG and Texas Red-conjugated avidin. (D) merged
played a diffuse chromatin pattern (asterisk) and did not label withimages from B and C.
annexin V, characteristics of viable, nonapoptotic cells.
Apoptosis detection by PARP cleavage
RESULTS
SDS-PAGE and immunoblots were probed with
Human renal tubular epithelial cells expressmouse antihuman PARP IgG and peroxidase-conju-
transfected murine Fas on the cell surfacegated goat antimouse IgG as described above. Apoptosis
To determine whether Fas function is regulated bywas defined by caspase-3-dependent cleavage of the 85
Fas expression levels, human RTC were transfected withkD degradation product from the intact 116 kD parent
graded concentrations of a eukaryotic expression vectorPARP protein, which is a signature step in the Fas ef-
for murine Fas. This in vitro model has several advan-fector pathway.
tages. First, human and mouse Fas require species-spe-
Statistics cific ligands, due to the heterogeneity of the respective
extracellular domains. Mouse agonistic Fas antibodiesAll experiments were performed a minimum of three
do not activate human Fas, and the effect of murine Fastimes with duplicate samples for each experimental con-
expression level on RTC apoptosis and JNK activity candition. Results are expressed as mean	 SE. Comparison
thus be assessed without a contribution from endogenousbetween two groups was made by the unpaired two-
Fas. Second, this model permits activation of low abun-tailed Student t test. Comparisons between more than
dance RTC Fas, which models basal in vivo conditions.two groups were made by one-way analysis of variance
Third, it represents a design improvement for mimickingwith the Bonferroni test for multiple comparisons. Statis-
tical significance is defined as P 
 0.05. a pathologic state of up-regulated RTC Fas expression
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Fig. 2 (Continued). (B) HRPT cells were trans-
fected with murine Fas cDNA expression vec-
tor (2 g/well) or empty pcDNA3 vector (2 g/
well), followed by incubation with agonistic
antimouse Fas IgG (5 g/ml, 14 hours, 37C)
or isotype control IgG (IgG, 5g/ml, 14 hours,
37C). Apoptosis was assessed by PARP cleav-
age product, as determined by immunoblot
analysis (Methods section). Molecular weight
markers (103) are shown at left.
Fig. 3. Fas-mediated apoptosis is dependent
upon transfected Fas expression level. HRPT
cells were transfected with mouse Fas cDNA
at indicated concentrations (per well) plus GFP
cDNA (1 g/well). Total transfected cDNA
concentrations (2 g/well) were kept constant
by supplementation with pcDNA3. Transfec-
tion efficiency, as determined by GFP fluo-
rescence, was 20 to 30% in each experimental
group. All groups were exposed to agonistic
antimouse Fas IgG (5 g/ml, 14 hours, 37C)
and then quantitatively analyzed for apoptosis
as described in the Methods section. (A) Apo-
ptosis detection by annexin V labeling of GFP-
positive cells. (B) Apoptosis detection by
DAPI-labeled nuclear morphology in GFP-
positive cells. *P 
 0.05 compared to groups
transfected with 0 to 0.03 g/well.
by avoiding exposure to cytokines or decreased oxygen
tension used in previous studies [6, 7, 9], which may
cause apoptosis in a Fas-independent manner. Figure 1
A demonstrates murine Fas expression in human RTC
following transient transfection. Only transfected cells
(indicated by green fluorescence in Fig. 1 B, D) expressed
mouse Fas in a plasma membrane distribution (Fig. 1 C,
D), indicating that transfected human RTC predomi-
nantly express the transmembrane mouse Fas isoform,
rather than the alternatively-spliced soluble isoform [13].
Surface mouse Fas protein expression was readily de-
tected up to 48 hours after transfection, with diminished
expression levels thereafter. Fas expression was not ob-
served in untransfected HRPT cells probed with anti-
Fig. 4. Transfected murine Fas cDNA plasmid concentration correlates
with surface Fas expression level. HRPT cells were transfected with
nofluorescence with hamster antimouse IgG, biotinylated goat antiham-1.0g/well empty pcDNA3 vector (control; thin line), 0.1g/well mouse
Fas cDNA  0.9 g/well pcDNA3 (low [Fas]; heavy line) or 1.0 g/ ster IgG and phycoerythrin (PE)-conjugated streptavidin. Cells were
analyzed by dual color flow cytometry, as previously described [6, 7].well mouse Fas cDNA (high [Fas]; dotted line) as described in the
Methods section. All three groups were co-transfected with GFP cDNA Phycoerythrin (PE) fluorescence in cells co-transfected with green fluo-
rescence protein (GFP) is shown.(1.0 g/well). Surface Fas expression was determined by indirect immu-
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Fig. 5. Endogenous RTC Fas activates JNK but does not stimulate
apoptosis. (Left panel) Untransfected HRPT cells were exposed to
known, potent JNK activators UV-C light (3000 mW · cm2, wavelength
254 nm) or hyperosmotic sorbitol (400 mmol/L, 30 min, 37C) as positive
controls. (Right panel) Untransfected RTC were incubated with agonis-
Fig. 6. Human RTC JNK activation correlates inversely with trans-tic anti-Fas IgM under conditions that do not stimulate apoptosis
fected murine Fas expression. HRPT cells were transfected with mouse(150 ng/mL, 15 min, 37C) or isotype control IgM (150 ng/mL, 15 min,
Fas cDNA at indicated concentrations (per well). Total transfected37C). Cell lysates were assayed for JNK activity by immune complex
cDNA concentrations (2 g/well) were kept constant by supplementa-kinase assay, using recombinant ATF-2 as the phosphorylation sub-
tion with pcDNA3. All groups were exposed to agonistic antimousestrate, as described in the Methods section.
Fas IgG (5 g/ml, 15 min, 37C) and lysates were analyzed for JNK
activity in (A), by immune complex kinase assay using GST-c-Jun as
substrate, and in (B) by immunoblotting with antiphosphospecific JNK
antibodies. (C) Immunoblots were stripped by incubation with 100
mmol/L -mercaptoethanol, 2% SDS, 62.5 mmol/L Tris-HCl, pH 6.7mouse Fas IgG and immunofluorescence microscopy
(50C, 30 min), and re-probed for Fas expression by immunoblotting(data not shown). with rabbit antimouse Fas IgG.
Mouse Fas cDNA-transfected human renal tubular
epithelial cells are susceptible to apoptosis
Fas-mediated apoptosis is dependent upon FasTo determine whether RTC undergo Fas-dependent
expression levelapoptosis after activation by agonistic antibody in this
To determine whether Fas transduces apoptosis in anheterologous expression system, human RTC were tran-
expression level-dependent fashion, HRPT cells were co-siently transfected with the maximum murine Fas cDNA
transfected with a GFP reporter at a fixed concentrationplasmid concentration that did not cause cell toxicity.
and mouse Fas cDNA at concentrations that ranged fromFigure 2A depicts a typical field containing untransfected
1 ng to 1g per well. Fas protein expression varied directlyand transfected cells, as indicated by fluorescence of a
with transfected Fas cDNA concentration, as measuredGFP reporter. In each experiment, approximately 25%
by immunoblot analysis (Fig. 6C). RTC with differingto 30% of cells were transfected. After incubation with
Fas expression levels were subsequently exposed to ago-agonistic antibody, transiently transfected RTC demon-
nistic antimouse Fas antibodies, and apoptotic cells werestrated an apoptotic morphology that included annexin
detected in the transfected cell population (indicated byV labeling of externalized phosphatidylserine (an early
GFP fluorescence) by annexin V labeling and nuclearfeature of apoptosis) and DAPI staining of condensed,
morphology. As shown in Figure 3, apoptosis was in-
fragmented chromatin (a late apoptotic feature, shown
duced only after Fas expression reached a threshold of
by arrows in Fig. 2A). In contrast, untransfected cells 0.03 to 0.10 g murine Fas expression vector per well.
displayed a diffuse chromatin pattern (shown by an aster- Maximum (8- to 10-fold) increase in apoptosis occurred
isk in Fig. 2A), and an absence of annexin V labeling. in RTC transfected with 0.3 to 1.0 g Fas cDNA per
Apoptosis was also demonstrated in this induced Fas well. The results support previous observations obtained
expression system by PARP cleavage (Fig. 2B) and with cytokine- or hypoxia-induced Fas expression by
TUNEL assay (not shown). No increase in apoptosis was demonstrating RTC Fas-mediated apoptosis is depen-
observed in Fas cDNA-transfected RTC in the absence dent on a threshold level of Fas expression [6, 7, 9].
of agonistic antibody exposure, indicating that induced
Transfected murine Fas cDNA plasmid concentrationFas expression did not result in self-oligomerization and
correlates with surface Fas expression levelligand-independent cell death, as has been reported by
others [34]. Taken together, results from these assays To determine the relationship between Fas cDNA
demonstrate that activated mouse Fas is capable of trans- plasmid concentration and surface Fas expression level,
ducing apoptosis signals when abundantly expressed in RTC were co-transfected with GFP cDNA and either
high or low Fas cDNA concentrations. GFP and Fashuman RTC.
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expression (as determined by PE fluorescence) were then
evaluated by dual color flow cytometry. Approximately
20% of cells were transfected in all groups, as determined
by GFP fluorescence (not shown). Figure 4 shows that
transfection with low concentration Fas cDNA resulted
in increased surface Fas expression in cells co-transfected
with GFP (mean 9.7 fluorescence units) compared to
cells co-transfected with empty vector and GFP (mean
4.8 fluorescence units). Furthermore, mean and median
PE fluorescence were not significantly different in the
low concentration Fas cDNA group, indicating that in-
creased PE fluorescence was not due to a small number
of cells with extremely high Fas expression. As expected,
Figure 4 demonstrates that cells transfected with higher
Fas cDNA concentration displayed greater Fas expres-
sion levels (mean 26.9 fluorescence units). These data
indicate that transient transfection with Fas cDNA
caused dose-dependent Fas expression per cell.
Endogenous RTC Fas activates JNK but does not
stimulate apoptosis
Renal tubular epithelial cells expressing low levels of
Fas, a model of the normal kidney state, do not undergo
apoptosis after incubation with agonistic antibody, sug-
gesting that constitutively expressed RTC Fas could me-
diate apoptosis-independent functions. Previous studies
have demonstrated that Fas stimulation triggers down-
stream JNK phosphorylation and activation, which is
unrelated to apoptosis in many systems [22, 24–26, 35,
36]. To determine whether RTC Fas at low constitutive
levels signals through JNK, untransfected human RTC
were incubated with agonistic antihuman Fas IgM under
conditions (150 ng/mL, 15 min) that do not induce apo-
ptosis (not shown). Figure 5 demonstrates that RTC Fas
stimulation caused JNK activation, as determined by im-
mune complex kinase assays. These results indicate that
RTC Fas activates JNK under conditions that are not
associated with apoptosis.
Human RTC JNK activation correlates inversely with
murine Fas expression
Agonistic Fas antibody activates JNK, but not apopto-
sis, in human RTC in which Fas expression has not been
up-regulated. Since apoptosis only occurs in RTC with
Fig. 7. Transfected RTC Fas activates JNK1. (A) HRPT cells were
for protein expression by immunofluorescence microscopy with anti-HAtransiently transfected with HA-tagged, dominant negative JNK1
antibodies (shown in red, see cover), as described in the Methods section.(JNK1-APF) and JNK2 (JNK2-APF) constructs (2 g/well). Controls
Nuclei were counterstained with DAPI (shown in blue, see cover). (C)included untransfected cells and cells transfected with empty LNCX
HRPT cells were transiently transfected with the murine Fas cDNAvector. Lysates were probed for dominant negative JNK isoform expres-
(0.03 g/well) and dominant negative JNK (JNK1-APF, 2 g/well) orsion by immunoblotting with anti-HA antibodies. Molecular weight mark-
empty vector (LNCX, 2 g/well) and then stimulated with agonisticers (103) are shown at left. Faint, nonspecific bands at 55 kD, such
anti-Fas IgG (5 g/ml, 15 min, 37C) or isotype control IgG (5 g/ml,as those seen in the two control lanes, have previously been recognized
15 min, 37C). Cell lysates were resolved by SDS-PAGE, and JNKby the anti-HA antibodies in immunoblots from other tissues [29]. (B)
activity was measured by immunoblot analysis with antiphosphospecificHRPT cells cultured on coverslips were transiently transfected with
JNK antibodies.HA-tagged JNK-APF constructs as described above, and then assessed
Khan et al: Apoptosis and JNK regulation by Fas72
Fig. 8. JNK activity is dispensable for trans-
fected Fas-dependent RTC apoptosis. (A)
HRPT cells with endogenous, constitutive Fas
expression were transfected with JNK1-APF
or empty vector (LNCX) as described above,
then incubated with agonistic antihuman Fas
IgM (150 ng/mL, 14 h, 37C), and assayed for
apoptosis by annexin V labeling of external-
ized phosphatidylserine or DAPI labeling of
condensed chromatin. *P 
 0.05 compared
to DAPI-labeled, LNCX-transfected cells. (B)
HRPT cells were transiently transfected with
murine Fas cDNA (1 g/well) and/or JNK1-
APF (1 g/well) constructs. Total transfected
cDNA concentrations (2 g/well) were kept
constant by supplementation with pcDNA3.
Cells were exposed to agonistic antimouse Fas
IgG or isotype control IgG (5 g/mL, 14 h,
37C), and lysates were probed for PARP
cleavage by immunoblot analysis as described
in the Methods section.
abundant Fas expression, activated Fas may stimulate expression level inversely correlates with Fas-induced
JNK activation, and suggest that JNK activation throughJNK activity at all levels of surface expression, but Fas
expressed at high levels may activate additional path- low density RTC Fas may be linked to apoptosis-inde-
pendent cell functions.ways required for apoptosis. To address the relationship
between Fas expression level and JNK activation, RTC
RTC Fas activates JNK1were transfected with graded Fas cDNA concentrations
and JNK activity was determined by immune complex The specific JNK isoform regulated by Fas was tested
by assaying Fas-dependent JNK activation in RTC ex-kinase assays and immunoblotting with phosphospecific
JNK antibodies (Fig. 6). JNK was activated in RTC trans- pressing dominant negative JNK isoform constructs [29,
37]. Figure 7 A and B demonstrate expression of dominantfected with the lowest Fas cDNA concentration follow-
ing stimulation with agonistic antibody (Fig. 6 A, B), negative JNKs in RTC by immunoblot and immunofluo-
rescence analyses, respectively. JNK isoform activationdespite only minimal Fas expression (Fig. 6C). Con-
versely, maximum RTC Fas expression was not associ- was determined in human RTC co-transfected with mu-
rine Fas cDNA concentrations that permit JNK activa-ated with JNK activation in response to agonistic Fas
antibody incubation (Fig. 6). In addition, apoptosis was tion (Fig. 6), and dominant negative JNK constructs. Fig-
ure 7C demonstrates that Fas ligation with agonistic Fasnot observed under these conditions, thereby demonstra-
ting that lack of Fas-dependent JNK activation was not antibody stimulated JNK activation, which was com-
pletely inhibited by JNK1-APF co-expression. Fas-depen-due to RTC death. These data indicate that RTC Fas
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Fig. 8 (Continued). (C) HRPT cells were
transiently transfected with GFP cDNA (0.67
g/well) plus murine Fas cDNA (0.67g/well)
and/or JNK1-APF (0.67 g/well) constructs.
Total transfected cDNA concentrations (2g/
well) were kept constant by supplementation
with pcDNA3. Cells were exposed to agonistic
antimouse Fas IgG (5 g/mL, 14 h, 37C) or
isotype control IgG (5g/mL, 14 h, 37C), and
assayed for apoptosis by annexin V labeling.
Results are expressed as percentage trans-
fected (GFP-fluorescent) cells that co-label
with annexin V. *P 
 0.05 compared to other
three experimental groups.
dent JNK activation was not inhibited by JNK2-APF sessed by annexin V assays (Fig. 8C) and nuclear mor-
co-expression (data not shown). These observations indi- phology by DAPI staining (not shown). Taken together,
cate that RTC Fas signals through the JNK1 isoform, the data indicate that JNK is neither necessary nor suffi-
which is consistent with data in other cell types [38]. cient for RTC Fas-dependent apoptosis.
JNK activity is dispensable for Fas-dependent
DISCUSSIONRTC apoptosis
Of the known apoptosis pathways, signaling throughFas-regulated JNK activity and apoptosis were directly
Fas has probably been the most comprehensively stud-tested in RTC expressing dominant negative JNK to deter-
ied. Data regarding Fas biology has been generated pri-mine if Fas-dependent JNK activity is dispensable for
marily in lymphocytes and cell lines with abundant en-RTC apoptosis. Transfection of basal human RTC (ab-
dogenous Fas expression. In RTC, we and others havesence of Fas up-regulation) with JNK1-APF alone caused
previously shown that prior exposure of RTC to endo-a slight increase in apoptosis in response to agonistic Fas
toxin, TNF, IL-1, or hypoxia increased cell surface Fasantibody, suggesting that JNK may actually play an anti-
expression, which mediated apoptosis upon agonistic Fasapoptotic role in RTC (Fig. 8A). RTC were then cotrans-
antibody stimulation [6, 7, 9]. The current study strength-fected with Fas cDNA at concentrations that mediate
ens these observations by demonstrating that RTC trans-apoptosis in the presence or absence of JNK1-APF cDNA,
fected with Fas cDNA, which is a method that minimizesat concentrations that inhibit Fas-dependent JNK activity.
unrelated effects of cytokines or hypoxia on cell viabilityFigure 8B is a representative immunoblot showing apo-
and signal transduction, resulted in Fas-stimulated apo-ptosis by PARP cleavage. The appearance of the 85 kD
ptosis only after a threshold level of expression wasPARP degradation product in RTC with induced Fas
achieved. Untransfected RTC or RTC transfected withexpression is evidence of caspase-3 activation, which is
lower concentrations of murine Fas expression vectora critical step in the Fas apoptosis pathway. Transfection
did not undergo apoptosis in response to agonistic Faswith dominant negative JNK did not inhibit PARP cleav-
age, and had no effect on Fas-regulated apoptosis, as as- antibody stimulation, suggesting that RTC, which consti-
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tutively express low levels of Fas, must be primed through Fas may also direct JNK activity through binding of
different docking molecules to selective cytoplasmic Fasup-regulated expression of Fas to function as a death
receptor. Furthermore, our studies are consistent with domains. For example, Wajant et al have shown that
overexpression of dominant negative FADD inhibitsthe concept that increased Fas density enhances the prob-
ability that Fas ligand or agonistic Fas antibody binding Fas-dependent apoptosis without affecting JNK activa-
tion [26], suggesting divergence of these two Fas func-promotes Fas oligomerization, which is required for apo-
ptosis [12]. tions and that the FADD binding domain is not required
for docking of upstream JNK activators. Deletion studiesPrevious studies from our laboratory indicate that Fas
functions as a classical death receptor after RTC Fas by Chang, Yang and Baltimore identified amino acids
192–200 within the Fas cytoplasmic domain as necessaryexpression is up-regulated. However, a role for constitu-
tively expressed Fas has not been described, and we now for FADD binding and apoptosis, but not JNK activation
[42]. Although these studies have provided a better un-tested whether constitutively expressed RTC Fas stimu-
lates signaling. Fas-induced JNK activation was exam- derstanding of Fas signaling as it relates to apoptosis,
the Fas domain(s) required for apoptosis-independentined because JNK has been linked to cytokine-induced
inflammation, and in some instances, shown to be dis- signaling remain unclear. Recent reports have generated
controversy regarding whether agonistic Fas antibodiespensable for apoptosis following Fas stimulation [24, 25,
39]. Cell type specificity, JNK isoform specificity, or con- represent an adequate stimulus for apoptosis compared
to multimerized Fas ligand in some cell types [43]. How-comitant activation of modifying signaling pathways may
determine if JNK activity is necessary for Fas-dependent ever, Fas clustering with pentameric anti-Fas IgM or
anti-Fas IgG plus protein A have been shown to faith-apoptosis [40]. Our data demonstrate that RTC undergo
apoptosis in the setting of up-regulated Fas expression fully mimic effects of multimerized Fas ligand [44]. Since
previous studies from our laboratory have shown that[6, 7], but under these conditions, RTC Fas stimulation
does not activate JNK. On the other hand, stimulation human RTC incubated with anti-Fas IgM [7] and mouse
RTC incubated with anti-Fas IgG plus protein G (unpub-of low abundance Fas led to JNK activation in the ab-
sence of apoptosis. Based upon these observations, we lished observation) do not undergo apoptosis, we con-
clude that absence of apoptosis in RTC under basal con-propose that RTC Fas expression levels modulate the
cellular response to Fas, and JNK activation is not neces- ditions is not due to inadequate stimulation of Fas, but
more likely results from insufficient Fas clustering duesary for RTC Fas-stimulated apoptosis. One possible
explanation for the absence of JNK activity in RTC with to low expression levels.
Based on our results, we propose the following modelinduced Fas expression is that cells were apoptotic, and
therefore not signaling. This is unlikely, however, since for expression-dependent Fas functions in RTC. Under
basal conditions, RTC are resistant to Fas-dependent apo-significant apoptosis does not result from only 15 minutes
of exposure to agonistic Fas antibodies. Furthermore, ptosis, despite constitutive, low level RTC Fas expression.
Since RTC are not actively dividing in vivo, programmedrobust Fas expression and decreased JNK activation
were observed in the same lysate (Fig. 6), indicating or accidental death is therefore not advantageous. In
contrast, RTC in an environment of chronic renal dis-that the protein synthesis machinery was intact. Another
potential explanation for the disparate effects of JNK ease, with constant exposure to inflammatory cytokines
and hypoxia, are induced to express Fas, and can undergoon cell death is derived from studies demonstrating that
JNK activity may be regulated by more than one upstream Fas-dependent apoptosis upon encountering Fas ligand-
bearing lymphocytes or RTC [6]. Apoptosis of RTC maypathway. In the setting of stress or inflammatory stimuli,
membrane-bound MEKK1 is rapidly stimulated, which comprise an adaptive response, by promoting deletion
of cells that are secreting pro-inflammatory cytokines orcatalyzes SEK1 and JNK activation as a “stress response”
[39, 41]. Alternatively, Fas-dependent JNK activation scar matrix proteins. Alternatively, RTC apoptosis may
be a maladaptive process, by causing hypertrophy of rem-during apoptosis is initiated by docking of the adapter
molecule FADD with activated Fas, which triggers cas- nant RTC, which has been associated with eventual tubu-
lar atrophy and renal disease progression. Our resultspase-8-mediated cleavage of MEKK1 at a plasma mem-
brane site. Truncated MEKK1 then translocates to the demonstrating JNK activity in RTC with low level Fas
expression raises intriguing questions regarding the rolecytosol and catalyzes SEK1 and JNK activation [35, 39].
In contrast to inflammatory stimuli, which rapidly acti- of Fas-dependent JNK activation in the transition of RTC
from an apoptosis-resistant to apoptosis-sensitive pheno-vate JNK, the kinetics of JNK activation in apoptosis
are relatively slow (1 to 6 hours) [25, 39]. Consistent with type. Although Fas-dependent JNK activation may
merely serve an anti-apoptotic function, Fas-generatedthis “kinetic model,” our data demonstrate early (15 min)
but not late (14 hours, not shown) JNK activation follow- signals may also promote apoptosis-independent mani-
festations of progressive renal disease, such as inflam-ing Fas stimulation, suggesting that RTC Fas may mediate
stress responses or inflammatory pathways through JNK. mation and fibrosis [19–21]. We speculate that interrup-
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